Kynam Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$45.8M	Buy	2,341,652 +871,111	+59%	+$25.9M	2.91%	10
2025 Q4	$45.8M	Sell	1,470,541 -2,957,386	-67%	-$81.1M	2.98%	8
2025 Q3	$95.6M	Hold	4,427,927	–	–	7.11%	6
2025 Q2	$61.9M	Sell	4,427,927 -272,073	-6%	-$3.69M	6.66%	7
2025 Q1	$63.4M	Buy	4,700,000 +1,373,738	+41%	+$23.4M	5.42%	7
2024 Q4	$63.8M	Buy	3,326,262 +814,967	+32%	+$17.7M	4.21%	10
2024 Q3	$57.1M	Buy	2,511,295 +761,295	+44%	+$12.4M	4.43%	10
2024 Q2	$22.8M	Buy	1,750,000 +1,616,123	+1,207%	+$22.4M	2.38%	14
2024 Q1	$2.34M	Sell	133,877 -474,038	-78%	-$9.19M	0.26%	23
2023 Q4	$13.2M	Sell	607,915 -91,766	-13%	-$1.45M	1.5%	17
2023 Q3	$10.7M	Sell	699,681 -9,817	-1%	-$187K	1.78%	14
2023 Q2	$16.9M	Buy	709,498 +165,895	+31%	+$4.26M	2.59%	13
2023 Q1	$13.8M	Sell	543,603 -491,094	-47%	-$15.7M	1.79%	16
2022 Q4	$30.2M	Buy	1,034,697 +34,697	+3%	+$799K	4.64%	6
2022 Q3	$20.5M	Buy	1,000,000 +409,857	+69%	+$7.37M	4.33%	7
2022 Q2	$6.83M	Buy	590,143 +317	+0.1%	+$4.26K	1.76%	14
2022 Q1	$10.9M	Buy	589,826 +301,892	+105%	+$5.8M	3.55%	10
2021 Q4	$5.69M	Buy	+287,934	New	+$5.36M	3.04%	11